Jodi was diagnosed with pleural mesothelioma more than 20 years ago, on December 27, 1999. She was only 26 years old. Despite being diagnosed around the holidays, Jodi focuses on...
Read PostNew Clinical Trial Available to Early-Stage Mesothelioma Patients
By: Devin Golden
December 12, 2019
A new clinical trial could help many recently diagnosed pleural mesothelioma patients. The study, hosted by researchers at Memorial Sloan-Kettering Cancer Center, will combine...
Read PostAsbestos Ban Bill Passes Committee Vote, Goes to House Floor Next
By: Devin Golden
November 27, 2019
A bill banning asbestos is one step closer to becoming law in the United States. Numerous websites, including Bloomberg Environment, reported that the House Energy and Commerce...
Read PostExperts continue exploring new treatment options for mesothelioma patients. Some ideas aren’t brand new but are tweaks to current forms of care. The recent rise of proton...
Read PostMesothelioma survivor Alexis Kidd received her mesothelioma diagnosis in 2007, more than 16 years ago. So excuse her for not remembering everything about the months leading up to...
Read PostLittle Doubt Left About Link Between Mesothelioma and Johnson & Johnson
By: Devin Golden
October 22, 2019
Two reports last week reinforce what many medical experts — and, unfortunately, even some mesothelioma patients — strongly believed. At least some of Johnson & Johnson’s...
Read PostThere are two primary surgeries for pleural mesothelioma patients: extrapleural pneumonectomy and pleurectomy with decortication. Some mesothelioma experts suggest a third: talc...
Read PostImagine it’s seven years from now. Or maybe it’s 10 or 20 years into the future. A person is told difficult-to-hear news from their doctor: They have mesothelioma, a rare and...
Read PostMesothelioma takes between 20 and 50 years to develop. Due to this long latency period, the asbestos-caused cancer affects middle-aged and elderly people most often. If a patient...
Read PostMesothelioma Clinical Trial Recruiting Patients for New Immunotherapy Treatment
By: Devin Golden
September 19, 2019
Immunotherapy drugs are commonplace in mesothelioma clinical trials. However, in many cases, these drugs can’t fight cancer alone. A new Phase 2 pleural mesothelioma clinical...
Read Post